医学
内科学
乌斯特基努马
克罗恩病
不利影响
胃肠病学
临床终点
维多利祖马布
临床试验
炎症性肠病
疾病
阿达木单抗
作者
Mathurin Fuméry,Antoine Defrance,Xavier Roblin,Romain Altwegg,Bénédicte Caron,Xavier Hébuterne,Carmen Stéfanescu,Antoine Meyer,Maria Nachury,David Laharie,Stéphane Nancey,Catherine Le Berre,Mélanie Serrero,Sophie Geyl,Cyrielle Giletta,Philippe Ah‐Soune,Nicolas Duveau,Mathieu Uzzan,Véred Abitbol,Amélie Biron
摘要
In a cohort of highly refractory patients with luminal CD and multiple prior drug failures including ustekinumab, risankizumab induction provided a clinical response in about 3 out of 4 patients and steroid-free clinical remission in about half of patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
皖公网安备34019202002308
